4-HYDROXY-3-(TRIFLUOROMETHOXY)BENZONITRILE, 95.0%, 1g

2-(1-Benzyl-piperidin-3-ylamino)-ethanol, 1g

4,6-Dimethyl-2-mercaptopyrimidine>98.0%(T)250g

2-(2-Fluoro-4-(trifluoromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 5g

3,3-Dimethyl-3,4-dihydro-2H-thieno[3,4-b][1,4]dioxepine, 97%, 100mg

3-Fluoro-2-(trifluoromethyl)benzylamine, 1g

4-Hydroxycyclohexanecarbonitrile, 95.0%, 500mg

2-Methoxy-6,7,8,9-tetrahydro-benzocyclohepten-5-one, 97.0%, 25g

N,N-Dimethyl-1-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine, 95.0%, 5g

2,3-Dibromo-5-methylpyridine, 98.0%, 100g

(3-(tert-Butylcarbamoyl)-4-chlorophenyl)boronic acid, 95.0%, 1g

Didecyldimethylammonium Bromide>98.0%(T)25g

Endo-M-W251N Recombinant: from Mucor hiemalis expressed in Escherichia coli (500m units/vial)1vial